Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Adiponectin serum concentrations in dyslipidemic subjects with small dense LDL particles (CROSBI ID 560833)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Vogrinc, Željka ; Ljubić, Hana ; Livaja, Goran ; Trbojević-Čepe, Milica ; Merkler, Marijan ; Božina, Nada ; Sertić, Jadranka ; Reiner, Željko Adiponectin serum concentrations in dyslipidemic subjects with small dense LDL particles // Clinical chemistry and laboratory medicine. 2009. str. S286-S286

Podaci o odgovornosti

Vogrinc, Željka ; Ljubić, Hana ; Livaja, Goran ; Trbojević-Čepe, Milica ; Merkler, Marijan ; Božina, Nada ; Sertić, Jadranka ; Reiner, Željko

engleski

Adiponectin serum concentrations in dyslipidemic subjects with small dense LDL particles

Background. Adiponectin is a peptide hormone secreted by the adipose tissue which plays a significant role in the regulation of lipid and carbohydrate metabolism. There is growing evidence that adiponectin has a protective effect against atherosclerosis and has recently been found to be decreased in coronary artery disease. Small dense LDL are potent atherogenic lipoprotein subclass and has been accepted as an emerging cardiovascular risk factor. We investigated the relationship between serum adiponectin levels and the occurrence of small dense LDL particles (pattern B) to evaluate the possible influence of this adipokine on LDL particle size distribution. Methods. We determined serum adiponectin concentrations in group of 43 dyslipidemic subjects with visceral adiposity and related metabolic syndrome, and in a group of 54 healthy blood donors with normal lipid profile and normal distribution of LDL particle size (pattern A). Serum adiponectin concentrations were determined by comercially available ELISA test (Mediagnost, Germany). LDL particle size determination was performed by gradient polyacrylamide gel electrophoresis developed in our laboratory. Results. The mean value of adiponectin concentrations in patient group was 18.513.3 g/mL and in the group of controls it was 11.87.8 g/mL. Pathologic LDL phenotypes (LDL phenotype B and LDL phenotype I) were detected in 29/43 (67.4%) dyslipidemic patients, and the mean value of adiponectin concentrations in this selected subgroup of patients was 11.77.2 g/mL. Conclusions. Our preliminary results suggest that an atherogenic lipoprotein phenotype including hypertriglyceridemia, low HDL-cholesterol and also small LDL particle size are associated with lowered serum adiponectin concentrations.

Adiponectin; dyslipidemia

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

S286-S286.

2009.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Clinical chemistry and laboratory medicine

Berlin: Walter de Gruyter

1434-6621

Podaci o skupu

18th IFCC - FESCC European Congress of Clinical Chemistry and Laboratory Medicine Euromedlab Innsbruck, Austrija

poster

07.06.2009-11.06.2009

Innsbruck, Austrija

Povezanost rada

nije evidentirano

Indeksiranost